HRT CRISIS AS PATCHES RUN OUT ON HIGH ST
Shortage forces desperate women to seek menopause treatment from abroad
WOMEN have been forced into buying HRT medication from abroad as it is now almost impossible to get in Britain.
Shortages have been going on for months but reached ‘crisis point’ this week as most Evorel patches – the UK market leader – disappeared from the shelves. Many alternatives were already out of stock and the two main pharmaceutical wholesalers have completely run out of all commonly-prescribed HRT patches, according to an audit seen by the Daily Mail.
Manufacturers are rationing what little stock they have with the support of the Department of Health, which has been slammed for its ‘disastrous’ handling of the crisis. Some women have been buying boxes for their friends from pharmacies while on holiday in Spain. One patient has even been air-freighting HRT from South Africa.
Around two-thirds of HRT treatments have been hit by shortages. They include Evorel and Elleste, the two most popular brands, which are prescribed to upwards of 100,000
women a year – more than half of those on the treatment. HRT is administered as patches, pills or gels and provides the oestrogen that the body stops producing during menopause. Several HRT tablets are also out of stock.
Dr Anne Henderson, an NHS consultant gynaecologist who runs a menopause clinic, said: ‘It is impossible to get patches – it is virtually impossible to run a clinic. I’ve been doing HRT for 30 years and I have never come across such an utter mess. For the first time I physically cannot prescribe for some patients.’
More than half of women on HRT are prescribed patches, which are applied once or twice a week below the waist.
Dr Henderson said: ‘Women are getting desperate. One woman popped into a pharmacy in Spain where you could buy Everol over the counter. She walked off with about six boxes. I have a patient whose mother is in South Africa, and is air-freighting six boxes over.
‘People on holiday are rushing to the pharmacies and coming back with HRT for friends, but it won’t last long because manufacturing issues are Europe-wide.’
Elizabeth Carr-Ellis, a menopause campaigner who has been forced to switch HRT brands due to the crisis, said: ‘I have had people messaging me offering to go to Spain for me and pick up HRT.’
Women have shared stories on social media of buying HRT from pharmacists over the counter in Spain. They are also
‘My patients are paying the price’
buying medication from websites – which experts warn could put their health in danger as drugs bought over the internet are often imitations.
The crisis started late last year when supply-chain issues that began in China forced some manufacturers to cease production. This led to raised demand for other brands and had a domino effect which ‘wiped out’ stock.
Shortages are expected to continue until next year.
Thousands of women have been forced to switch brands, causing crippling symptoms including night sweats.
In recent days Evorel HRT patches, which are made by Belgian firm Janssen and have a market share of 40 per cent, have gone out of stock.
An audit seen by the Mail last night revealed all Evorel patches are unavailable in the two largest pharmaceutical wholesalers – AAH, which supplies Lloyds, and Alliance, owned by the same firm as Boots. No alternative patches are available. FemSeven Sequi and Conti patches, made by Theramex, have been out of stock for months and will not be available until 2020.
Estradot patches, an alternative HRT product produced by Swiss giant Novartis, are not subject to shortages.
But Novartis does not produce enough Estradot to meet the increased demand, meaning patches fly off the shelves. It has had to ration orders.
Doctors say health bosses should have foreseen the crisis.
Dr Henderson said: ‘My patients are paying the price for disastrous handling by Janssen and the Department of Health.’
The UK Department of Health said: ‘We have not restricted HRT but support Novartis’s decision to manage demand.’
Janssen said: ‘Availability of the Evorel range continues to be impacted by the lack of availability of alternative products.’
The Scottish Government works with the UK Government, NHS Scotland and Community Pharmacy Scotland to manage any drug shortages. It is aware of supply issues with HRT.
A spokesman said: ‘Any patient affected should discuss alternative treatments with a doctor.’
Professor Andrew Goddard, President of the Royal College of Physicians, said: ‘The situation is... unlikely to have the resilience to survive a major stress like No Deal Brexit.’